A combination of antibodies against Bm86 and Subolesin inhibits engorgement of Rhipicephalus australis (formerly Rhipicephalus microplus) larvae in vitro
Loading...
Date
Authors
Trentelman, Jos J.A.
Teunissen, Hendry
Kleuskens, Jos A.G.M.
Van de Crommert, Jos
De la Fuente, Jose
Hovius, Joppe W. R.
Schetters, Theo
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
Abstract
BACKGROUND: Rhipicephalus microplus is a hard tick species that has a high impact on cattle health and production
in tropical and subtropical regions. Recently, ribosomal DNA and morphological analysis resulted in the reinstatement of R. australis as a separate species from R. microplus. Both feed on cattle and can transmit bovine pathogens
such as Anaplasma and Babesia species. The current treatment with acaricides is becoming increasingly less effective
due to the emergence of resistant tick strains. A promising alternative can be found in the form of anti-tick vaccines.
The available commercial vaccines can be used to control tick infestation, but the lack of a knockdown effect (>90%
reduction in tick numbers as seen with effective acaricides) hampers its widespread use, hence higher efficacious
vaccines are needed. Instead of searching for new protective antigens, we investigated the efficacy of vaccines that
contain more than one (partially) protective antigen. For screening vaccine formulations, a previously developed in
vitro feeding assay was used in which R. australis larvae are fed sera that were raised against the candidate vaccine
antigens. In the present study, the efficacy of the Bm86 midgut antigen and the cytosolic Subolesin (SUB) antigen
were evaluated in vitro.
RESULTS: Antiserum against recombinant Bm86 (rBm86) partially inhibited larval engorgement, whereas antiserum
against recombinant SUB (rSUB) did not have any effect on feeding of larvae. Importantly, when larvae were fed a
combination of antiserum against rBm86 and rSUB, a synergistic effect on signifcantly reducing larval infestations was
found. Immunohistochemical analysis revealed that the rBm86 antiserum reacted with gut epithelium of R. australis
larvae, whereas the antiserum against rSUB stained salivary glands and rectal sac epithelium.
CONCLUSIONS: Combining anti-Bm86 and anti-subolesin antibodies synergistically reduced R. australis larval feeding
in vitro. Rhipicephalus australis is a one host tick, meaning that the larvae develop to nymphs and subsequently adults
on the same host. Hence, this protective effect could be even more pronounced when larvae are used for infestation
of vaccinated cattle, as the antibodies could then affect all three developmental stages. This will be tested in future in
vivo experiments.
Description
Keywords
Artifcial tick feeding, In vitro screening, Subolesin, Vaccine, Rhipicephalus microplus, Rhipicephalus australis, Recombinant Bm86 (rBm86), Recombinant SUB (rSUB), Larvae, Antiserum
Sustainable Development Goals
Citation
Trentelman, J.J.A., Teunissen, H., Kleuskens, J.A.G.M. et al. A combination of antibodies against Bm86 and Subolesin inhibits engorgement of Rhipicephalus australis (formerly Rhipicephalus microplus) larvae in vitro. Parasites and Vectors 12, 362 (2019). https://doi.org/10.1186/s13071-019-3616-3.
